跳至主要内容
临床试验/EUCTR2013-003889-14-GB
EUCTR2013-003889-14-GB进行中(未招募)1 期

A randomised, placebo controlled trial of azithromycin for the prevention of chronic lung disease of prematurity in preterm infants - Treat Infections In Neonates 2 v1.0

Institut National de la Santé et de la Research Médicale0 个研究点目标入组 810 人开始时间: 2015年6月12日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
810

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • a) Pre-term, =28 weeks gestational age (i.e. 28 weeks and 6 days, including infants born as one of a multiple birth)
  • b) Requirement for respiratory support within 12hrs of birth (intubated, or by non-invasive mechanical ventilation inc. continuous positive airway pressure)
  • c) Presence of an indwelling intravenous line for drug administration
  • d) Inborn, or born at site within the recruiting centre’s neonatal network where follow up will be possible
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 810
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range 0
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range 0

排除标准

  • a) In the opinion of the Principal Investigator, babies unlikely to survive until 48 hours after birth
  • b) Exposure to another macrolide antibiotic
  • c) Presence of major surgical or congenital abnormalities (not including patent ductus arteriosus or patent foramen ovale)
  • d) Infants born as part of a multiple pregnancy of three or more (i.e. triplets or more)
  • d) Participation in other clinical trials involving other investigational medicinal products

研究者

发起方
Institut National de la Santé et de la Research Médicale

相似试验